Core Viewpoint - The company has adjusted the grant price of its 2025 restricted stock incentive plan from 10.96 yuan per share to 10.79 yuan per share, following the completion of necessary decision-making procedures and legal opinions [1][4][6]. Group 1: Decision-Making Process - The company held multiple meetings to review and approve the adjustment of the grant price for the 2025 restricted stock incentive plan [1][2]. - Legal opinions were provided by Guangdong Xinda (Suzhou) Law Firm regarding the adjustment and related matters [4][6]. - The adjustment was authorized by the company's first temporary shareholders' meeting in 2025, allowing the board to handle related matters without further shareholder approval [6][7]. Group 2: Adjustment Details - The adjustment of the grant price was necessitated by the company's profit distribution plan, which included a cash dividend of 1.67 yuan per 10 shares [5]. - The formula used for the adjustment was P = P0 - V, where P0 is the original grant price, V is the cash dividend per share, resulting in the new grant price of 10.79 yuan per share [5][6]. - The adjusted grant price applies to both the initial grant and the reserved portion of the restricted stock [5][6]. Group 3: Impact and Compliance - The adjustment complies with relevant laws and regulations, including the Management Measures for Equity Incentives of Listed Companies [6]. - The company asserts that the adjustment will not materially affect its financial status or operational results, nor will it harm the interests of the company and its shareholders [6][7]. - The Compensation and Assessment Committee confirmed that the adjustment process was legal and compliant with the authorized scope [6].
长华化学: 关于调整2025年限制性股票激励计划授予价格的公告